Navigation Links
Lomb in Medical News

Bausch & Lomb Receives Approval of Crystalens HD in Quarter Diopter Steps

ALISO VIEJO, Calif., July 13 /PRNewswire/ -- Bausch & Lomb announced today that it has received approval from the Food and Drug Administration (FDA) to market the Crystalens HD(TM) in quarter diopter steps in the United States. The Crystalens accommodating intraocular lens (IOL) ...

Bausch & Lomb Vision Care Strengthens Its Commitment to ReNu(R) Brand and the Eye Care Community

Portfolio Repositioning Introduces ReNu(R) Fresh Lens Comfort(TM) and ReNu(R) Sensitive Eyes(R) to Meet Different Consumer Needs; Dedicated Sales Force Spearheads Efforts to Engage Eye Care Practitioner Community ROCHESTER, N.Y., June 26 /PRNewswire/ -- Bausch & Lomb Vision Care announce...

Bausch & Lomb Kicks Off U.S. Consumer Online Marketing Campaign for SofLens(R) Daily Disposable Contact Lenses

ROCHESTER, N.Y., June 26 /PRNewswire/ -- Bausch & Lomb has initiated a national multimillion dollar consumer online marketing campaign surrounding the U.S. launch of SofLens (R) daily disposable contact lenses. This multi-faceted campaign targets adults ages 25 to 34 and is designed to gen...

Bausch & Lomb Announces New Center for Patient Insights

Unique Initiative Delivers Industry Trends, News and Insights to Eye Care Practitioners Nationwide ROCHESTER, N.Y., June 26 /PRNewswire/ -- Bausch & Lomb announces the launch of the Center for Patient Insights - a first-of-its-kind initiative that strives to increase access to unbiased...

Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye')

- Besivance Adds to Bausch & Lomb's Expanding Ocular Pharmaceuticals Portfolio and Offers New Therapeutic Option for a Wide Range of Ocular Bacterial Pathogens(1) - MADISON, N.J., May 29 /PRNewswire/ -- Bausch & Lomb, a world leader in eye health, today announced that the U.S. Food...

Bausch & Lomb Appoints Global Vision Care and North American Vision Care Presidents

ROCHESTER, N.Y., May 11 /PRNewswire/ -- Bausch & Lomb, the global eye health company, has named Peter Valenti III as corporate vice president and global president, Vision Care, effective July 1. He joined Bausch & Lomb in January 2009 as president, North America, Vision Care. Before ...

Bausch & Lomb and 20/10 Perfect Vision Finalize Refractive Surgery Joint Venture

MUNICH, Germany, April 30 /PRNewswire/ -- Bausch & Lomb, the global eye health company, and 20/10 Perfect Vision AG, the femtosecond laser developer, have completed their transaction to form a joint venture focused on the laser vision correction industry. Financial terms were not disclosed. ...

Bausch & Lomb Japan Names Mitsuo Hirose as Chairman

TOKYO, April 1 /PRNewswire/ -- Bausch & Lomb Japan has named Mitsuo (Mike) Hirose as chairman, effective immediately. Mr. Hirose has served on the subsidiary's Board of Directors since January 2009. Mr. Hirose brings exceptional executive experience to Bausch & Lomb Japan, comp...

VIDEO from Medialink and Bausch & Lomb: Bausch & Lomb Partners With Visual Therapy to Help Women Nationwide 'See a New You'

NEW YORK, March 30 /PRNewswire/ -- Bausch & Lomb has announced a partnership in the U.S., with Visual Therapy , a luxury lifestyle consultancy firm that helps individuals identify their perfect style type. The firm will help bring the benefits of multifocal contact lenses to life for women a...

Bausch & Lomb Partners With Visual Therapy to Help Women Nationwide 'See a New You'

Partnership Kicks Off with U.S. Online Sweepstakes at www.goodbyereaders.com ROCHESTER, N.Y., March 30 /PRNewswire/ -- Bausch & Lomb has announced a partnership in the U.S., with Visual Therapy , a luxury lifestyle consultancy firm that helps individuals identify their perfect sty...
Lomb in Medical Technology

Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study

... time point. By way of comparison, in published results from clinical studies of DME patients using sustained release intravitreal FA in Bausch & lomb Incorporated's product Retisert(R), a surgically implanted intravitreal drug delivery device containing 0.59 mg FA approved for the treatment of chron...

Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema

...ctor. Retisert(R) is FDA approved for the treatment of uveitis. Vitrasert(R) is FDA approved for the treatment of AIDS-related CMV Retinitis. Bausch & lomb own the trademarks Vitrasert(R) and Retisert(R). pSivida has licensed the technologies underlying both of these products to Bausch & Lomb. The technol...

Enrollment Begins on Human PK Study for Medidur(TM) FA

...ctor. Retisert(R) is FDA approved for the treatment of uveitis. Vitrasert(R) is FDA approved for the treatment of AIDS-related CMV Retinitis. Bausch & lomb own the trademarks Vitrasert(R) and Retisert(R). pSivida has licensed the technologies underlying both of these products to Bausch & Lomb. The technol...
Lomb in Medical Products

Bausch & Lomb Concentrated Cleaner

Description: Bausch & Lomb concentrated cleaner is a sterile, concentrated homogeneous surfactant solution containing alkyl ether sulfate, ethoxylated alkyl phenol, tri-quaternary cocoa-based phospholipid and silica gel as cleaning agents....
Company:Bausch & Lomb, Inc.

PureVision Contact Lenses

Description:... Upgrade your hydrogel contact lens-wearing patients to Bausch & lomb PureVision silicone hydrogel contact lenses with enhanced aspheric optical design. PureVision contact lenses deliver the ultimate technology in materi...
Company:Bausch & Lomb, Inc.

PreserVision® Soft Gels Lutein Eye Vitamins

Description:... Bausch & lomb PreserVision® Soft Gel Lutein patented formula is based on the clinically proven Bausch & lomb PreserVision® AREDS formula, with the beta-car...f the eye responsible for central vision. Bausch & lomb PreserVision® Lutein brand contains 5 mg of Fl...
Company:Bausch & Lomb, Inc.

PreserVision® Soft Gels AREDS Eye Vitamins

Description:... Bausch & lomb PreserVision® AREDS formula is the one and only eye vitamin and mineral supplement clinically proven effective in the 10-year National Institutes ...
Company:Bausch & Lomb, Inc.

Hansatome Microkeratome

Description:... Engineered for high volume surgical efficiencies, the Bausch & lomb Hansatome Microkeratome, a corneal resection instrument, features an automated pivoting motion that provides smooth, resistance-free travel with a sup...
Company:Bausch & Lomb Storz

SofPort System

Description:... Bausch & lomb introduces the SofPort System the latest advance in IOL and inserter technology. The system integrates the SoFlex SE IOL and the MPort SI inserter, p...
Company:Bausch & Lomb Storz

1 Piece PMMA IOLs

Description:... Posterior Chamber Lenses: The Bausch & lomb PMMA Posterior Chamber Intraocular Lenses are intended to be used for primary implantation for the visual correction of aphakia in patients 60 years o...
Company:Bausch & Lomb Storz

C11UB single-piece silicone lens

Description:... The Bausch & lomb UV-Absorbing, Silicone Posterior Chamber Intraocular Lens Model C11UB is indicated for primary implantation for the visual correction of aphakia in pa...
Company:Bausch & Lomb Storz

SoFlex Multipiece Foldable IOL

Description:... The Bausch & lomb SoFlex™ UV-Absorbing, Silicone Posterior Chamber Intraocular Lenses are intended to be used for primary implantation for the visual correction o...
Company:Bausch & Lomb Storz

3 Piece PMMA IOLs

Description:... Posterior Chamber Lenses: The Bausch & lomb PMMA Posterior Chamber Intraocular Lenses are intended to be used for primary implantation for the visual correction of aphakia in patients 60 years o...
Company:Bausch & Lomb Storz
Lomb in Biological Technology

Trusted LASIK Surgeons Welcomes Leading Laser Expert and Inventor Jon Dishler, M.D., to Its Unique LASIK Eye Surgeon Directory for Consumers

...to his major contributions to IntraLase and a Clarity Award In appreciation of Leadership and Experience Wavefront Symposium presented by Bausch & lomb "We are pleased to add a true innovator in laser eye surgery like Dr. Dishler to our unique LASIK directory. He is among the most experience...

Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals

... Executive Officer of Danube. Prior to joining Danube, since 2004, Dr. Levy served as Corporate Vice President and Chief Medical Officer of Bausch & lomb worldwide. He was responsible for clinical development and research, global product safety and medical affairs. In this role Dr. Levy drove the develo...

Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement

...ucts. Retisert(R) is FDA approved for the treatment of uveitis. Vitrasert(R) is FDA approved for the treatment of AIDS-related CMV Retinitis. Bausch & lomb owns the trademarks Vitrasert(R) and Retisert(R). pSivida has licensed the technologies underlying both of these products to Bausch & Lomb. The techno...
Other Tags
(Date:3/6/2015)... March 06, 2015 Last month, Dr. Dental ... oral hygiene and heart health. To mark the occasion, the ... hygiene can positively affect heart health. , According to ... heart health. Experts note that taking good care of oral ... that the two have some commonalities. For example, inflammation is ...
(Date:3/6/2015)... March 06, 2015 A California Superior ... http://www.filevaginalmeshlawsuit.com/ ) filed against Johnson & Johnson and its ... $5.7 million to a woman who suffered serious complications ... treat stress urinary incontinence. In a verdict rendered on ... was defectively designed, and that doctors and patients were ...
(Date:3/6/2015)... Based on recent data from the National Health ... have self-reported, doctor-diagnosed arthritis. And children suffer from ... to those who suffer with arthritis with its “Get ... their purchase when they buy directly from the company, ... a tube of the product will be donated on ...
(Date:3/6/2015)... Protein identification is increasingly being used ... research including drug discovery, diagnostics, immunology and oncology. ... valued at $1,569.00 million in 2014 and is ... to reach $2,600.28 million in 2019. , Protein ... based on protein size, shape, sequence and physiochemical ...
(Date:3/6/2015)... Today, the California Healthcare Institute (CHI), ... Ph.D., Director of the National Institutes of Health (NIH) ... a roundtable discussion regarding the vibrancy of the California ... Obama's Precision Medicine Initiative. , Joint Statement from Dr. ... of the School of Medicine, UC San Diego; Joe ...
Breaking Medicine News(10 mins):Health News:Dr. Dental Celebrates American Heart Month 2Health News:Transvaginal Mesh Lawyers at Bernstein Liebhard Comment on Latest Trial Victory for Ethicon Mesh Lawsuit Plaintiff 2Health News:Transvaginal Mesh Lawyers at Bernstein Liebhard Comment on Latest Trial Victory for Ethicon Mesh Lawsuit Plaintiff 3Health News:Transvaginal Mesh Lawyers at Bernstein Liebhard Comment on Latest Trial Victory for Ethicon Mesh Lawsuit Plaintiff 4Health News:Topical BioMedics Offers Help for Those Who Suffer with Arthritis with New “Get Arthritis Relief” Initiative 2Health News:Topical BioMedics Offers Help for Those Who Suffer with Arthritis with New “Get Arthritis Relief” Initiative 3Health News:Topical BioMedics Offers Help for Those Who Suffer with Arthritis with New “Get Arthritis Relief” Initiative 4Health News:Topical BioMedics Offers Help for Those Who Suffer with Arthritis with New “Get Arthritis Relief” Initiative 5Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 2Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 3Health News:California’s Life Sciences Sector Hosts NIH Director in San Diego 2Health News:California’s Life Sciences Sector Hosts NIH Director in San Diego 3
(Date:3/5/2015)... In Brazil , cloud computing is fast ... and 42 percent planning to invest in them by the ... the companies will be investing in these solutions for the ... the region are currently opting for the private cloud model, ... attention in the coming years. This trend is in line ...
(Date:3/4/2015)... Mar. 04, 2015 Research and Markets ... of the "Global Biometrics Market Forecast and ... The market for biometric authentication systems is ... 14% till 2020 The driving forces ... security needs, government projects and constant development in ...
(Date:3/3/2015)... FOREST, Calif. , March 3, 2015 ... the leading provider of advanced cryogenic logistics ... markets including immunotherapies, stem cells, cell lines, ... and reproductive medicine, today announced the expansion ... Cancer Research Centers, ("Fred Hutch") Clinical ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
Other Contents